Physician profile

Sauman Rafii

Pain Medicine (Anesthesiology) · Austin, TX

NPI 1811128887

$23,503.96

in general payments reported to CMS, 2019-2025

39 companies · $3,480 in 2025

The $3,480 reported for 2025 was more than what 90% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).

See the full distribution for Pain Medicine (Anesthesiology)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$12,777.13
Travel and Lodging$975.54
Gift$15.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $5,025.97 2019-2025 Wavewriter Alpha Prime 16, General - Pain Management
Medtronic, INC. $3,301.04 2022-2025 Intellis Adaptivestim, Inceptiv, Synchromedii
Abbott Laboratories $3,186.35 2021-2025 Proclaim, Penta, Octrode
Vertiflex, INC. $1,979.52 2019
Si-Bone, INC. $1,704.05 2019-2025
Spinal Simplicity, LLC $1,406.77 2023-2025 Ha Minuteman G3-R, Liberty Si
Relievant Medsystems, INC. $1,142.22 2021-2023 Intracept
Abbvie INC. $732.77 2022-2025
Nalu Medical, INC. $723.96 2023-2024 Nalu Neurostimulation System
Collegium Pharmaceutical, INC. $659.57 2019-2025 Belbuca, Xtampza, Nucynta
Globus Medical, INC. $429.72 2025 Senza
Genesys Orthopedics Systems, L.L.C. $399.46 2024 Sacroiliac Joint Fusion System
Biodelivery Sciences International, INC. $326.68 2019-2021
Pfizer INC. $276.45 2019-2024
Scilex Pharmaceuticals INC. $237.66 2019-2024 Ztlido
Show all 39 companies
CompanyGeneral paymentsYearsTop products
Allergan, INC. $213.29 2021-2022
Grt US Holding, INC. $202.09 2021-2022
Pacira Therapeutics, INC. $177.32 2019
Stryker Corporation $165.00 2025 Mild Device Kit, Ivas
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $163.38 2022-2025 Relistor
Horizon Therapeutics Plc $122.75 2019-2021
Biohaven Pharmaceutical Holding Company LTD. $116.51 2022
Pacira Pharmaceuticals Incorporated $115.86 2020-2023 Iovera, Zilretta
Averitas Pharma INC. $90.62 2023-2024 Qutenza
Lundbeck LLC $87.64 2024 Vyepti
Uswm, LLC $75.10 2021-2022
Amgen INC. $62.77 2022
Protega Pharmaceutials INC $57.57 2025 Roxybond
Valinor Pharma, LLC $40.56 2025 Movantik
Merz Pharmaceuticals, LLC $39.95 2023 Xeomin
Hikma Pharmaceuticals USA $37.75 2022-2023 Kloxxado
Foundation Fusion Solutions, LLC $37.34 2024
Arbor Pharmaceuticals, INC. $32.62 2019
Ibsa Pharma INC. $29.37 2023-2024 Tirosint, Licart, Licart
Redhill Biopharma INC. $28.11 2022
Azurity Pharmaceuticals, INC. $21.70 2024 Horizant
Lilly USA, LLC $21.61 2024 Emgality
Kaleo, INC. $17.42 2019
Ipsen Biopharmaceuticals, INC $15.44 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sauman Rafii

$23,503.96

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $3,480 reported for 2025 was more than what 90% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).

https://glasscript.com/doctor/1353927/sauman-rafii

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.